Roger S Goody

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 11

Top Topics

Saccharomyces Cerevisiae

Binding Protein

Regulatory T Cells

Papillary Thyroid

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Goebel, Tonia Kirschner, Sandra Koska, Amrita Rai, Petra Janning, Stefano Maffini, Helge Vatheuer, Paul Czodrowski, Roger S Goody, Matthias Philipp Müller, Daniel Rauh
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. eLife 12 (2023)
Lisa Goebel, Tonia Kirschner, Sandra Koska, Amrita Rai, Petra Janning, Stefano Maffini, Helge Vatheuer, Paul Czodrowski, Roger S Goody, Matthias Philipp Müller, Daniel Rauh
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. eLife 12 (2023)
Lisa Goebel, Tonia Kirschner, Sandra Koska, Amrita Rai, Petra Janning, Stefano Maffini, Helge Vatheuer, Paul Czodrowski, Roger S Goody, Matthias Philipp Müller, Daniel Rauh
Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. eLife 12 (2023)
Amrita Rai, Anurag Kumar Singh, Nathalie Bleimling, Guido Posern, Ingrid R Vetter, Roger S Goody
Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. Nature communications 13 (1) (2022)
Amrita Rai, Nathalie Bleimling, Ingrid R Vetter, Roger S Goody
The mechanism of activation of the actin binding protein EHBP1 by Rab8 family members. Nature communications 11 (1) (2020)
Sadasivam Jeganathan, Matthias Philipp Müller, Imtiaz Ali, Roger S Goody
Assays for Nucleotide Competitive Reversible and Irreversible Inhibitors of Ras GTPases. Biochemistry 57 (31) (2018)
Imtiaz Ali, Sungmin Eu, Daniel Koch, Nathalie Bleimling, Roger S Goody, Matthias Philipp Müller
Structure of the tandem PX-PH domains of Bem3 from Saccharomyces cerevisiae. Acta crystallographica. Section F, Structural biology communications 74 (Pt 5) (2018)
Amrita Rai, Roger S Goody, Matthias Philipp Müller
Multivalency in Rab effector interactions. Small GTPases 10 (1) (2017)
Matthias P Müller, Sadasivam Jeganathan, Angelika Heidrich, Jeremy Campos, Roger S Goody
Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity. Scientific reports 7 (1) (2017)
Matthias Philipp Müller, Roger S Goody
Molecular control of Rab activity by GEFs, GAPs and GDI. Small GTPases 9 (1-2) (2017)
Amrita Rai, Anastasia Oprisko, Jeremy Campos, Yangxue Fu, Timon Friese, Aymelt Itzen, Roger S Goody, Emerich Mihai Gazdag, Matthias Philipp Müller
bMERB domains are bivalent Rab8 family effectors evolved by gene duplication. eLife 5 (2016)